These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1839971)

  • 1. New fluorine-substituted analogue of eticlopride with high affinity toward dopamine D2 receptors.
    Watanabe K; Fukumura T; Sasaki S; Maeda M; Takehara S
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3211-4. PubMed ID: 1839971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron-emitting N-[18F]fluoroalkyl and [18F]fluoropyrrolidinyl analogues of eticlopride as potential in vivo radioligands for dopamine D2 receptors.
    Maeda M; Sasaki S; Fukumura T; Fukuzawa E; Watanabe K; Kojima M; Tahara T; Masuda K; Ichiya Y
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1793-8. PubMed ID: 1394695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.
    Mathis CA; Bishop JE; Gerdes JM; Whitney JM; Brennan KM; Jagust WJ
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):571-88. PubMed ID: 1399687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of dopamine D2-receptor selective antagonists.
    Högberg T
    Drug Des Discov; 1993; 9(3-4):333-50. PubMed ID: 8400011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
    Halldin C; Högberg T; Farde L
    Nucl Med Biol; 1994 May; 21(4):627-31. PubMed ID: 9234320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.
    Martelle JL; Nader MA
    CNS Neurosci Ther; 2008; 14(3):248-62. PubMed ID: 18801115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds.
    Högberg T; Bengtsson S; de Paulis T; Johansson L; Ström P; Hall H; Ogren SO
    J Med Chem; 1990 Apr; 33(4):1155-63. PubMed ID: 1969484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain.
    Hall H; Köhler C; Gawell L
    Eur J Pharmacol; 1985 May; 111(2):191-9. PubMed ID: 4018125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New fluorinated dopamine D2 ligands with benzofuran skeleton. The synthesis and in vitro evaluation.
    Sasaki S; Takao F; Watanabe K; Obana N; Maeda M; Fukumura T; Takehara S
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):296-300. PubMed ID: 8500197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro affinity for dopamine D-2 receptor of N-fluorine-substituted analogs of eticlopride.
    Fukumura T; Dohmoto H; Maeda M; Fukuzawa E; Kojima M
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1740-2. PubMed ID: 2208388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligands.
    Kiesewetter DO; Kawai R; Chelliah M; Owens E; McLellan C; Blasberg RG
    Int J Rad Appl Instrum B; 1990; 17(4):347-56. PubMed ID: 2143753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D
    Shaik AB; Boateng CA; Battiti FO; Bonifazi A; Cao J; Chen L; Chitsazi R; Ravi S; Lee KH; Shi L; Newman AH
    J Med Chem; 2021 Oct; 64(20):15313-15333. PubMed ID: 34636551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory effects of D2 receptors in the ventral tegmental area on the mesocorticolimbic dopaminergic pathway.
    Chen NN; Pan WH
    J Neurochem; 2000 Jun; 74(6):2576-82. PubMed ID: 10820220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
    Sheppard B; Lehmann J; Cope ZA; Brown RW
    Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC; Montgomery AJ; Grasby PM; Hume SP
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.